The hematologist from UC Health discussed the role of allogeneic stem cell transplant at first remission based on risk stratification.
This content originally appeared on our sister site, OncLive.
Stay at the forefront of cutting-edge science with CGT—your direct line to expert insights, breakthrough data, and real-time coverage of the latest advancements in cell and gene therapy.